References
- Sørensen A, Jespersen S, Katzenstein TL, et al. Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-Bissau. Infect Dis (Lond). 2016;48:604–611.
- Madec Y, Szumilin E, Genevier C, et al. Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. Aids. 2009;23:853–861.
- Federal Ministry of Health. National guidelines for HIV and AIDS treatment and care in adolescents and adults. Abuja Nigeria, Abuja: Federal Ministry of Health; 2010.
- Hanley JA, Negassa A, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157:364–375.
- Tang AM, Sheehan HB, Jordan MR, et al. Predictors of weight change in male HIV-positive injection drug users initiating antiretroviral therapy in Hanoi, Vietnam. AIDS Res Treat. 2011;2011:890308.
- Ross-Degnan D, Pierre-Jacques M, Zhang F, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010;10:42.
- Yuh B, Tate J, Butt AA, et al. Weight change after antiretroviral therapy and mortality. Clin Infect Dis. 2015;11:civ192.
- Mashinya F, Alberts M, Colebunders R, et al. Weight status and associated factors among HIV-infected people on antiretroviral therapy in rural Dikgale, Limpopo, South Africa. Afr. J Prim Health Care Fam Med. 2016;8:1230.
- Weinberg JL, Kovarik CL. The WHO clinical staging system for HIV/AIDS. Virtual Mentor. 2010;12:202.